Home / Treatment Library / Xeomin®
Precision wrinkle treatment. A clear, evidence-aware guide to candidacy, treatment, recovery, limitations and next steps.
Your anatomy, expression and goals guide every recommendation—so the result still feels unmistakably like you.
Xeomin® is incobotulinumtoxinA, and it is the purified member of this group. Its manufacturing separates the active neurotoxin from the hemagglutinin and non-hemagglutinin proteins that accompany it in the other three products — which is why it is often described as the “naked” toxin. Its FDA cosmetic labeling covers moderate-to-severe upper facial lines: glabellar lines, forehead lines and lateral canthal lines in adults.
Xeomin’s difference is in the vial rather than in the injection. It is the only one of the four supplied without the accessory proteins.
The Xeomin® label describes separating the active ingredient from the hemagglutinin and non-hemagglutinin proteins through a series of purification steps. Botox® Cosmetic, Dysport® and Jeuveau® all include those accessory proteins. This is a genuine formulation difference, not a marketing distinction.
Glabellar, forehead and lateral canthal lines all sit within Xeomin’s labeled cosmetic use in adults — broader than Dysport® or Jeuveau®, which are labeled for the glabella alone.
Purified or not, the same rule applies: Xeomin® units cannot be compared to or converted into units of any other botulinum toxin product. Switching to Xeomin® means a new dose plan, not a translated one.
Product selection is a clinical decision made with you at consultation. Nothing here is a recommendation for a specific product, and no toxin can be dosed from a web page.
Adults who want the upper face treated — Xeomin®’s cosmetic labeling covers glabellar lines, forehead lines and lateral canthal lines in adults — and anyone who would rather have a formulation without the accessory proteins that accompany the other three. A good candidate understands that the result is temporary, that asymmetry is possible, and that the dose is built from their own anatomy rather than translated from a previous product.
Treatment may be deferred for pregnancy or breastfeeding, active infection at an injection site, known allergy to an ingredient, certain neuromuscular disorders, or symptoms that require medical evaluation. Tell the provider about all medications, supplements, prior toxin products and any swallowing or breathing problems.
These are practical planning ranges, not promises. Your consultation determines the exact plan.
Your provider reviews health history, prior toxin use and how your brow, forehead and outer eye move. All three areas sit within what Xeomin® is labeled for.
Xeomin® is the purified toxin, separated from its hemagglutinin and non-hemagglutinin proteins. Switching to it from another product means a new dose plan, not a converted one; its label is explicit that units are not comparable between products.
Small measured injections with a fine needle, then aftercare and a follow-up window. Movement settles over the first two weeks.
Expected effects can include temporary redness, tenderness, bruising, swelling or asymmetry. Every botulinum toxin product carries a boxed warning about distant spread of toxin effect: rare but serious risks include swallowing, speaking or breathing difficulty. Units of one product cannot be compared to or converted into units of another. Treatment cannot be guaranteed and must follow an individualized examination.
Small differences in depth, angle, dose and muscle selection change the outcome. An experienced medical injector can distinguish dynamic lines from volume loss, protect brow and eyelid function, plan around asymmetry and recognize complications early.
Treatment is in-office only. Telehealth can answer general questions, but facial examination, consent and injections occur at an Identity Aesthetics location.
Pricing: From $12 per unit. Final cost depends on the number of units selected after assessment. Always ask about current promotions and volume savings.
Medical-content evidence review: July 30, 2026. Content is written for patient education and structured from current primary regulatory, labeling and professional sources. It has not been individualized to your medical history. Product labeling and guidance can change; a licensed Identity Aesthetics provider confirms current suitability, informed consent and treatment details before care.
Bring your goals, questions, medication list and prior treatment history. We will help you decide whether Xeomin®—or an alternative—makes sense.
